$LUNG stock has now risen 12% today, according to our price data from Polygon. There has been approximately $1,312,230 of trading volume.
Here is what we see in our data on $LUNG (you can track the company live on Quiver's $LUNG stock page):
$LUNG Insider Trading Activity
$LUNG insiders have traded $LUNG stock on the open market 26 times in the past 6 months. Of those trades, 0 have been purchases and 26 have been sales.
Here’s a breakdown of recent trading of $LUNG stock by insiders over the last 6 months:
- GLENDON E. III FRENCH (President and CEO) has made 0 purchases and 5 sales selling 76,618 shares for an estimated $110,796.
- DANIEL P FLORIN sold 23,321 shares for an estimated $46,408
- DAVID AARON LEHMAN (GENERAL COUNSEL) has made 0 purchases and 8 sales selling 22,515 shares for an estimated $33,635.
- GEOFFREY BERAN ROSE (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 8 sales selling 14,054 shares for an estimated $20,982.
- SRIKANTH RADHAKRISHNAN (Chief Science &Techn. Officer) has made 0 purchases and 4 sales selling 10,483 shares for an estimated $14,990.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$LUNG Hedge Fund Activity
We have seen 58 institutional investors add shares of $LUNG stock to their portfolio, and 68 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SILVERCREST ASSET MANAGEMENT GROUP LLC removed 1,264,233 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $1,630,860
- VESTAL POINT CAPITAL, LP removed 830,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,834,300
- SOLEUS CAPITAL MANAGEMENT, L.P. added 750,000 shares (+36.8%) to their portfolio in Q1 2026, for an estimated $967,500
- BANK OF AMERICA CORP /DE/ added 439,027 shares (+60.3%) to their portfolio in Q1 2026, for an estimated $566,344
- GSA CAPITAL PARTNERS LLP removed 351,705 shares (-46.6%) from their portfolio in Q4 2025, for an estimated $777,268
- AQR CAPITAL MANAGEMENT LLC added 298,659 shares (+506.9%) to their portfolio in Q1 2026, for an estimated $385,270
- VANGUARD GROUP INC added 298,348 shares (+13.3%) to their portfolio in Q4 2025, for an estimated $659,349
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$LUNG Revenue
$LUNG had revenues of $20.6M in Q1 2026. This is a decrease of -8.66% from the same period in the prior year.
You can track LUNG financials on Quiver Quantitative's LUNG stock page.
You can access data on LUNG stock through the Quiver Quantitative API.
$LUNG Government Contracts
We have seen $123,145 of award payments to $LUNG over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- ZEPHR VALVES: $22,414
- PROSTHETICS:IMPLANT: $20,281
- PROS - BILL ONLY - BRONCHOSCOPY: $18,840
- PULMONARY PROSTHETIC: $14,950
- VALVE- LUNG: $12,400
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$LUNG Price Targets
Multiple analysts have issued price targets for $LUNG recently. We have seen 2 analysts offer price targets for $LUNG in the last 6 months, with a median target of $9.5.
Here are some recent targets:
- Jason Kolbert from D. Boral Capital set a target price of $14.0 on 04/30/2026
- Jon Young from Canaccord Genuity set a target price of $5.0 on 03/05/2026
You can track data on $LUNG on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
